marketcaparena
Search

    ODTX

    Odyssey Therapeutics, Inc.

    Company overview

    Market capitalization
    $1.03B
    Employees
    100
    Latest publication
    2026-09-29
    About Odyssey Therapeutics, Inc.

    Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor"associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Total Revenue0USD1,918,000USD1,755,000USD
    Research Development32,321,000USD38,774,000USD31,479,000USD
    Selling General Administrative7,350,000USD7,952,000USD7,397,000USD
    Total Operating Expenses39,780,000USD46,726,000USD38,876,000USD
    Operating Income-39,780,000USD-44,808,000USD-37,121,000USD
    Interest Income1,708,000USD1,156,000USD1,773,000USD
    Interest Expense10,000USD2,000USD4,000USD
    Net Interest Income1,698,000USD1,154,000USD1,769,000USD
    Income Before Tax-38,199,000USD-38,295,000USD-35,885,000USD
    Income Tax Expense63,000USD——
    Tax Provision63,000USD140,000USD47,000USD
    Net Income-38,262,000USD-38,435,000USD-35,932,000USD
    Net Income From Continuing Ops-38,262,000USD-38,435,000USD-35,932,000USD
    Ebit-38,189,000USD——
    Ebitda-37,018,000USD——
    Depreciation And Amortization1,171,000USD——
    Reconciled Depreciation1,171,000USD1,299,000USD1,293,000USD
    Total Other Income Expense Net1,581,000USD5,359,000USD-533,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Revenue2,976,000USD4,472,000USD1,037,000USD0USD
    Gross Profit2,976,000USD———
    Research Development126,616,000USD112,579,000USD112,279,000USD101,755,000USD
    Selling General Administrative37,516,000USD27,116,000USD22,197,000USD21,021,000USD
    Total Operating Expenses164,132,000USD139,695,000USD134,476,000USD122,776,000USD
    Operating Income-161,156,000USD-135,223,000USD-133,439,000USD-122,776,000USD
    Interest Income6,348,000USD8,489,000USD8,792,000USD3,924,000USD
    Interest Expense17,000USD18,000USD335,000USD291,000USD
    Net Interest Income6,331,000USD8,471,000USD8,457,000USD3,633,000USD
    Income Before Tax-149,574,000USD-128,852,000USD-125,491,000USD-124,318,000USD
    Income Tax Expense-927,000USD———
    Tax Provision-927,000USD469,000USD447,000USD347,000USD
    Net Income-148,647,000USD-129,321,000USD-125,938,000USD-124,665,000USD
    Net Income From Continuing Ops-148,647,000USD-129,321,000USD-125,938,000USD-124,665,000USD
    Ebit-149,557,000USD———
    Ebitda-144,646,000USD———
    Depreciation And Amortization4,911,000USD———
    Reconciled Depreciation4,911,000USD5,193,000USD4,908,000USD2,764,000USD
    Total Other Income Expense Net11,582,000USD-2,100,000USD-509,000USD-5,175,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets229,070,000USD197,435,000USD221,535,000USD
    Intangible Assets160,000USD570,000USD696,000USD
    Other Current Assets9,352,000USD6,156,000USD4,929,000USD
    Total Liab752,764,000USD579,962,000USD570,801,000USD
    Total Stockholder Equity-523,694,000USD-382,527,000USD-349,266,000USD
    Other Current Liab8,618,000USD753,000USD—
    Capital Stock0USD0USD1,000USD
    Retained Earnings-606,401,000USD-419,492,000USD-382,656,000USD
    Good Will14,072,000USD13,346,000USD14,253,000USD
    Cash35,719,000USD59,136,000USD39,435,000USD
    Cash And Short Term Investments175,749,000USD——
    Total Current Assets185,101,000USD135,510,000USD159,833,000USD
    Total Current Liabilities22,211,000USD28,415,000USD25,106,000USD
    Net Debt-9,592,000USD——
    Short Term Debt5,374,000USD——
    Short Long Term Debt Total26,127,000USD——
    Long Term Investments0USD0USD0USD
    Short Term Investments140,030,000USD70,218,000USD115,469,000USD
    Accounts Payable8,219,000USD6,319,000USD5,325,000USD
    Property Plant Equipment Net24,476,000USD39,470,000USD41,269,000USD
    Property Plant Equipment Gross39,583,000USD50,894,000USD51,675,000USD
    Accumulated Other Comprehensive Income-147,000USD——
    Common Stock Shares Outstanding47,174,156shares47,174,156shares47,174,156shares
    Non Current Assets Total43,969,000USD61,925,000USD61,702,000USD
    Non Current Liabilities Total730,553,000USD551,547,000USD545,695,000USD
    Non Current Liabilities Other6,242,000USD10,224,000USD9,841,000USD
    Non Currrent Assets Other5,261,000USD8,539,000USD5,484,000USD
    Net Working Capital162,890,000USD107,095,000USD134,727,000USD
    Unclassified Non Current Liabilities724,311,000USD541,323,000USD535,854,000USD
    Unclassified Equity82,854,000USD36,965,000USD33,389,000USD
    Unclassified Current Liabilities—21,343,000USD19,781,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Assets269,788,000USD197,435,000USD286,521,000USD317,150,000USD
    Intangible Assets262,000USD570,000USD910,000USD1,179,000USD
    Other Current Assets9,298,000USD6,156,000USD5,539,000USD7,669,000USD
    Total Liab758,066,000USD579,962,000USD549,229,000USD461,770,000USD
    Total Stockholder Equity-488,278,000USD-382,527,000USD-262,708,000USD-144,620,000USD
    Other Current Liab13,392,000USD753,000USD——
    Capital Stock0USD0USD1,000USD1,000USD
    Retained Earnings-568,139,000USD-419,492,000USD-289,091,000USD-158,171,000USD
    Good Will14,327,000USD13,346,000USD13,554,000USD12,879,000USD
    Cash41,687,000USD59,136,000USD52,545,000USD241,043,000USD
    Cash And Short Term Investments181,358,000USD———
    Total Current Assets190,656,000USD135,510,000USD192,536,000USD248,712,000USD
    Total Current Liabilities26,475,000USD28,415,000USD22,087,000USD22,797,000USD
    Net Debt-14,576,000USD———
    Short Term Debt5,211,000USD———
    Short Long Term Debt Total27,111,000USD———
    Long Term Investments35,198,000USD0USD29,102,000USD0USD
    Short Term Investments139,671,000USD70,218,000USD134,452,000USD0USD
    Accounts Payable7,872,000USD6,319,000USD7,729,000USD8,051,000USD
    Property Plant Equipment Net26,013,000USD39,470,000USD46,733,000USD52,774,000USD
    Property Plant Equipment Gross40,173,000USD50,894,000USD53,592,000USD55,223,000USD
    Accumulated Other Comprehensive Income245,000USD———
    Common Stock Shares Outstanding27,561,183shares47,174,156shares47,174,156shares47,174,156shares
    Non Current Assets Total79,132,000USD61,925,000USD93,985,000USD68,438,000USD
    Non Current Liabilities Total731,591,000USD551,547,000USD527,142,000USD438,973,000USD
    Non Current Liabilities Other6,133,000USD10,224,000USD8,414,000USD8,202,000USD
    Non Currrent Assets Other3,332,000USD8,539,000USD3,686,000USD1,606,000USD
    Net Working Capital164,181,000USD107,095,000USD170,449,000USD225,915,000USD
    Unclassified Non Current Liabilities725,458,000USD541,323,000USD518,728,000USD426,012,000USD
    Unclassified Equity79,616,000USD36,965,000USD26,382,000USD13,550,000USD
    Unclassified Current Liabilities—21,343,000USD14,358,000USD14,746,000USD
    Long Term Debt———4,759,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Net Income-38,262,000USD-38,435,000USD-35,932,000USD
    Depreciation1,171,000USD1,299,000USD1,293,000USD
    Stock Based Compensation2,587,000USD2,989,000USD2,664,000USD
    Other Non Cash Items659,000USD-4,624,000USD2,482,000USD
    Change In Working Capital-7,190,000USD-5,284,000USD-2,543,000USD
    Total Cash From Operating Activities-41,035,000USD-38,621,000USD-34,288,000USD
    Capital Expenditures-148,000USD-927,000USD-265,000USD
    Free Cash Flow-41,183,000USD-39,548,000USD-34,553,000USD
    Investments34,950,000USD35,000,000USD47,405,000USD
    Total Cashflows From Investing Activities34,802,000USD——
    Net Borrowings-24,000USD-35,000USD—
    Total Cash From Financing Activities484,000USD200,000USD6,819,000USD
    Change In Cash-5,725,000USD-4,225,000USD19,701,000USD
    Begin Period Cash Flow44,897,000USD62,346,000USD42,645,000USD
    End Period Cash Flow39,172,000USD58,121,000USD62,346,000USD
    Other Cashflows From Financing Activities-143,000USD——
    Unclassified Operating Cash Flow—5,434,000USD-2,252,000USD
    Issuance Of Capital Stock——7,470,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Net Income-148,647,000USD-129,321,000USD-125,938,000USD-124,665,000USD
    Depreciation4,911,000USD5,193,000USD4,908,000USD2,764,000USD
    Stock Based Compensation14,322,000USD8,686,000USD6,261,000USD5,517,000USD
    Other Non Cash Items4,674,000USD5,730,000USD4,354,000USD17,086,000USD
    Change In Working Capital-4,728,000USD-3,307,000USD896,000USD-544,000USD
    Total Cash From Operating Activities-129,468,000USD-117,471,000USD-112,728,000USD-99,842,000USD
    Capital Expenditures-1,232,000USD-764,000USD-5,056,000USD-13,027,000USD
    Free Cash Flow-130,700,000USD-118,235,000USD-117,784,000USD-112,869,000USD
    Investments-103,068,000USD97,548,000USD-159,988,000USD0USD
    Total Cashflows From Investing Activities-103,943,000USD———
    Total Cash From Financing Activities215,646,000USD26,979,000USD92,076,000USD182,717,000USD
    Issuance Of Capital Stock212,458,000USD27,477,000USD96,571,000USD177,765,000USD
    Change In Cash-17,449,000USD6,342,000USD-185,667,000USD69,825,000USD
    Begin Period Cash Flow62,346,000USD56,004,000USD241,671,000USD171,846,000USD
    End Period Cash Flow44,897,000USD62,346,000USD56,004,000USD241,671,000USD
    Other Cashflows From Investing Activities357,000USD———
    Other Cashflows From Financing Activities212,458,000USD———
    Unclassified Financing Cash Flow-209,270,000USD———
    Unclassified Operating Cash Flow—-4,452,000USD-3,209,000USD—
    Net Borrowings——-4,759,000USD4,876,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.